Racial differences in coronary artery calcification are not attributed to differences in lipoprotein particle sizes: the Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) Study.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 17239697)

Published in Am Heart J on February 01, 2007

Authors

Aryan N Aiyer1, Kevin E Kip, Oscar C Marroquin, Suresh R Mulukutla, Daniel Edmundowicz, Steven E Reis

Author Affiliations

1: Cardiovascular Institute, University of Pittsburgh, Pittsburgh, PA, USA. aiyeran@upmc.edu

Articles citing this

Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study. Aging Cell (2008) 3.24

Influence of race and socioeconomic status on sleep: Pittsburgh SleepSCORE project. Psychosom Med (2008) 2.16

Blood pressure dipping and sleep disturbance in African-American and Caucasian men and women. Am J Hypertens (2008) 1.92

Intra-individual variability in sleep duration and fragmentation: associations with stress. Psychoneuroendocrinology (2009) 1.67

Sleep-disordered breathing and excessive daytime sleepiness in chronic kidney disease and hemodialysis. Clin J Am Soc Nephrol (2011) 1.45

Relation of obstructive sleep apnea to coronary artery calcium in non-obese versus obese men and women aged 45-75 years. Am J Cardiol (2014) 1.45

Genetics of leukocyte telomere length and its role in atherosclerosis. Mutat Res (2011) 1.44

Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis. Kidney Int (2009) 1.19

Racial differences in the burden of coronary artery calcium and carotid intima media thickness between Blacks and Whites. Neth Heart J (2015) 0.97

Napping, nighttime sleep, and cardiovascular risk factors in mid-life adults. J Clin Sleep Med (2010) 0.95

Associations of Framingham risk score profile and coronary artery calcification with sleep characteristics in middle-aged men and women: Pittsburgh SleepSCORE study. Sleep (2011) 0.95

Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial. Obesity (Silver Spring) (2012) 0.92

Biogeographic ancestry, self-identified race, and admixture-phenotype associations in the Heart SCORE Study. Am J Epidemiol (2012) 0.92

Leukocyte telomere length and coronary artery calcium. Am J Cardiol (2015) 0.87

Low life purpose and high hostility are related to an attenuated decline in nocturnal blood pressure. Health Psychol (2010) 0.82

Traditional and nontraditional cardiovascular risk factors in comorbid insomnia and sleep apnea. Sleep (2014) 0.82

Effects of enamel matrix genes on dental caries are moderated by fluoride exposures. Hum Genet (2014) 0.81

Characterization of lipid profile in coronary heart disease patients in Sudan. Indian Heart J (2013) 0.81

Airflow Limitation and Endothelial Dysfunction. Unrelated and Independent Predictors of Atherosclerosis. Am J Respir Crit Care Med (2016) 0.78

Variants on chromosome 4q21 near PKD2 and SIBLINGs are associated with dental caries. J Hum Genet (2017) 0.75

Acute physiologic effects of secondhand smoke exposure in children. Nicotine Tob Res (2010) 0.75

Genetic Association of MMP10, MMP14, and MMP16 with Dental Caries. Int J Dent (2017) 0.75

A dietary cholesterol challenge study to assess Chlorella supplementation in maintaining healthy lipid levels in adults: a double-blinded, randomized, placebo-controlled study. Nutr J (2016) 0.75

Articles by these authors

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA (2006) 11.22

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res (Phila) (2010) 5.81

Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology (2008) 3.89

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol (2006) 3.25

Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA (2004) 3.17

Low prevalence of "ideal cardiovascular health" in a community-based population: the heart strategies concentrating on risk evaluation (Heart SCORE) study. Circulation (2011) 2.99

Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J (2013) 2.79

Vertebral compression fractures: pain reduction and improvement in functional mobility after percutaneous polymethylmethacrylate vertebroplasty retrospective report of 245 cases. Radiology (2003) 2.76

Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol (2008) 2.74

Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol (2010) 2.68

Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J (2006) 2.67

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation (2004) 2.67

Abdominal adiposity and hot flashes among midlife women. Menopause (2008) 2.65

A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med (2008) 2.60

Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med (2008) 2.60

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol (2006) 2.57

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation (2004) 2.50

Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol (2007) 2.49

Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA (2007) 2.43

Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation (2012) 2.41

Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J (2013) 2.21

Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21

Influence of race and socioeconomic status on sleep: Pittsburgh SleepSCORE project. Psychosom Med (2008) 2.16

Racial differences in coronary artery calcification in older adults. Arterioscler Thromb Vasc Biol (2002) 2.15

Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol (2007) 2.14

Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol (2011) 2.10

Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause (2011) 2.06

The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation. Circulation (2006) 2.03

A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol (2005) 1.94

Blood pressure dipping and sleep disturbance in African-American and Caucasian men and women. Am J Hypertens (2008) 1.92

Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort. Am J Epidemiol (2007) 1.90

Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40-49 in Japan than in the US, despite a less favorable profile of major risk factors. Int J Epidemiol (2004) 1.86

Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries. Circ Cardiovasc Interv (2008) 1.84

Bacterial vaginosis (BV) and the risk of incident gonococcal or chlamydial genital infection in a predominantly black population. Sex Transm Dis (2005) 1.82

Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology (2009) 1.80

Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry. J Am Coll Cardiol (2007) 1.77

Coronary and aortic calcification in women with a history of major depression. Arch Intern Med (2005) 1.77

Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol (2003) 1.74

Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina. J Am Coll Cardiol (2002) 1.67

Intra-individual variability in sleep duration and fragmentation: associations with stress. Psychoneuroendocrinology (2009) 1.67

Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care (2011) 1.65

History of hot flashes and aortic calcification among postmenopausal women. Menopause (2010) 1.63

Screening children to identify families at increased risk for cardiovascular disease. Pediatrics (2006) 1.62

Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol (2004) 1.62

Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice. Am Heart J (2003) 1.61

Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) (2004) 1.57

Relationship between coronary artery calcification and other measures of subclinical cardiovascular disease in older adults. Arterioscler Thromb Vasc Biol (2002) 1.55

Sleep symptoms predict the development of the metabolic syndrome. Sleep (2010) 1.55

Volumetric BMD and vascular calcification in middle-aged women: the Study of Women's Health Across the Nation. J Bone Miner Res (2006) 1.54

Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. JACC Cardiovasc Interv (2008) 1.49

Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol (2006) 1.48

A cross-sectional association of obesity with coronary calcium among Japanese, Koreans, Japanese Americans, and U.S. whites. Eur Heart J Cardiovasc Imaging (2013) 1.45

Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? Am J Obstet Gynecol (2008) 1.45

Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol (2003) 1.44

Self-reported and accelerometer-derived physical activity levels and coronary artery calcification progression in older women: results from the Healthy Women Study. Menopause (2013) 1.42

Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry. Catheter Cardiovasc Interv (2013) 1.41

Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med (2007) 1.41

Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol (2007) 1.40

Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol (2007) 1.40

Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial. JACC Cardiovasc Interv (2009) 1.38

Direct stenting compared to balloon predilation in drug-eluting stents: one-year outcomes from the DEScover Registry. Catheter Cardiovasc Interv (2011) 1.37

Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation study. Psychosom Med (2004) 1.36

The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE). Am Heart J (2009) 1.36

The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol (2002) 1.31

Clinical utility of regadenoson for assessing fractional flow reserve. JACC Cardiovasc Interv (2011) 1.29

The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol (2008) 1.29

Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation (2004) 1.28

Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation (2006) 1.25

Infliximab dose intensification in Crohn's disease. Inflamm Bowel Dis (2007) 1.25

The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol (2006) 1.23

Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum (2002) 1.23

Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab (2012) 1.21

Non-cardiac findings on coronary electron beam computed tomography scanning. J Thorac Imaging (2004) 1.21

Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Imaging (2010) 1.21

Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol (2004) 1.21

Subclinical coronary atherosclerosis: racial profiling is necessary! Am Heart J (2006) 1.20

25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum (2009) 1.20

Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol (2004) 1.20

Vaginal douching and development of bacterial vaginosis among women with normal and abnormal vaginal microflora. Sex Transm Dis (2007) 1.20

Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. Am Heart J (2003) 1.19

Marital status, marital quality, and atherosclerotic burden in postmenopausal women. Psychosom Med (2003) 1.15

Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis (2011) 1.14